論文 - 詳細
| RRC ID | 36774 |
|---|---|
| 著者 | Takaya A, Peng WX, Ishino K, Kudo M, Yamamoto T, Wada R, Takeshita T, Naito Z. |
| タイトル | Cystatin B as a potential diagnostic biomarker in ovarian clear cell carcinoma. |
| ジャーナル | Int J Oncol |
| Abstract |
Epithelial ovarian cancer (EOC) consists of four major subtypes: clear cell carcinoma (CCC), endometrioid adenocarcinoma (EA), mucinous adenocarcinoma (MA) and serous adenocarcinoma (SA). Relative to the other subtypes, the prognosis of CCC is poor due to a high recurrence rate and chemotherapy resistance, but CCC-specific biomarkers have yet to be identified. With the aim of identifying diagnostic and treatment biomarkers for CCC, we analyzed 96 cases of EOC (32 CCC, 13 EA, 19 MA, 32 SA) using liquid chromatography/mass spectrometry (LC/MS) followed by immunohistochemistry (IHC) and quantitative reverse transcription PCR (RT-qPCR). Semi-quantification of protein differences between subtypes showed upregulation of 150 proteins and downregulation of 30 proteins in CCC relative to the other subtypes. Based on hierarchical clustering that revealed a marked distinction in the expression levels of cystatin B (CYTB) and Annexin A4 (ANXA4) in CCC relative to the other subtypes, we focused the study on CYTB and ANXA4 expression in EOCs by IHC, RT-qPCR and western blot analyses using tissue specimens and cultured cells. As a result, compared to the other subtypes, CCC showed significantly high expression levels of CYTB and ANXA4 in the analyses. To examine the possibility of CYTB and ANXA4 as serum diagnostic biomarkers of CCC, we checked the protein levels in conditioned media and cell lysates using culture cells. Compared with the other subtypes, CCC cell lines showed a significantly higher level of expression of CYTB in both conditioned media and cell lysates, while ANXA4 showed a higher level of expression in cell lysates only. Our results demonstrate that CYTB and ANXA4 overexpression may be related to carcinogenesis and histopathological differentiation of CCC. CYTB may be a secreted protein, and may serve as a potential serum diagnostic biomarker of CCC, while ANXA4 may be useful as an intracellular marker. |
| 巻・号 | 46(4) |
| ページ | 1573-81 |
| 公開日 | 2015-4-1 |
| DOI | 10.3892/ijo.2015.2858 |
| PMID | 25633807 |
| MeSH | Adenocarcinoma, Clear Cell / blood Adenocarcinoma, Clear Cell / diagnosis* Adenocarcinoma, Clear Cell / pathology* Adult Aged Aged, 80 and over Annexin A4 / genetics Annexin A4 / metabolism* Biomarkers, Tumor / blood Biomarkers, Tumor / genetics Biomarkers, Tumor / metabolism* Cell Line, Tumor Chromatography, Liquid / methods Culture Media, Conditioned / pharmacology Cystatin B / genetics Cystatin B / metabolism* Female Gene Expression Regulation, Neoplastic Humans Mass Spectrometry / methods Middle Aged Ovarian Neoplasms / blood Ovarian Neoplasms / diagnosis* Ovarian Neoplasms / pathology* Real-Time Polymerase Chain Reaction / methods Young Adult |
| IF | 3.899 |
| 引用数 | 12 |
| WOS 分野 | ONCOLOGY |
| オルトメトリクス指標 |
オルトメトリクス指標項目
|
| 最多言及媒体 | Patent(IFI CLAIMS) |
| 各媒体での言及数の合計 | 1 |
| 過去6か月間でのオルトメトリクス指標の変動値 | 0.0 |
| リソース情報 | |
| ヒト・動物細胞 | JHOC-5(RCB1520) JHOC-9(RCB2226) JHOM-1(RCB1676) JHOS-2(RCB1521) |